Biomarkers of genotoxicity and genomic instability in a non-human primate, Cebus libidinosus (Cebidae, Platyrrhini), exposed to nitroimidazole derivatives

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 721, Issue 1, 2011, Pages 108-113

  Mudry, Marta Dolores ^a,b   Martinez, Romari Alejandra ^c   Nieves, Mariela ^a,b   Carballo, Marta Ana ^a,d  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c DEPARTAMENTO DE CIÊNCIAS BIOLÓGICAS   (Brazil)

^d INFIBIOC Facultad de Farmacia y Bioquímica Universidad de Buenos Aires ^*  (Argentina)

Author keywords

Cebus libidinosus; Genotoxicity; Heterochromatin; Nitroimidazoles; Sister chromatid exchange

Indexed keywords

METRONIDAZOLE; ORNIDAZOLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CEBUS LIBIDINOSUS; CELL DAMAGE; CELL DIVISION; CELL PROLIFERATION; CHROMOSOME 11Q; CHROMOSOME 12Q; CHROMOSOME 13Q; CHROMOSOME 17; CHROMOSOME 17Q; CHROMOSOME 1P; CHROMOSOME 1Q; CHROMOSOME 2Q; CHROMOSOME 4Q; CHROMOSOME 6Q; CHROMOSOME 8Q; CHROMOSOME BANDING PATTERN; CHROMOSOME SIZE; CONTROLLED STUDY; DRUG EXPOSURE; GENETIC MARKER; GENOMIC INSTABILITY; GENOTOXICITY; HETEROCHROMATIN; LYMPHOCYTE; MITOSIS; NONHUMAN; PRIMATE; PRIORITY JOURNAL; SISTER CHROMATID EXCHANGE;

ANIMALS; BIOLOGICAL MARKERS; CEBUS; DNA DAMAGE; GENOMIC INSTABILITY; METRONIDAZOLE; MITOTIC INDEX; MUTAGENS; ORNIDAZOLE; SISTER CHROMATID EXCHANGE;

CEBIDAE; CEBUS LIBIDINOSUS; PLATYRRHINI; PRIMATES;

EID: 79951670648     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2011.01.002     Document Type: Article

References (50)

1. VandeBerg J., Williams-Blanguero S. Advantages and limitations of nonhuman primates as animal models in genetic research on complex diseases. J. Med. Primatol. 1997, 26:113-119.
2. F. García Haro, Evolución cromosómica en Simiiformes. Homologías, Reorganizaciones y Heterocromatina, Tesis Doctoral, Universidad Autónoma de Barcelona, España, 2001, 252 pp.
3. Seuánez H.N., Bonvicino C.R., Moreira M.A.M. The primates of the neotropics: genomes and chromosomes. Cytogenet. Genome Res. 2005, 108:38-46.
4. Amaral P.J.S., Finotelo L.F.M., de Oliveira E.H.C., Pissinatti A., Nagamachi C.Y., Pieczarka J.C. Phylogenetic studies of the genus Cebus (Cebidae-Primates) using chromosome painting and G-banding. BMC Evol. Biol. 2008, 8:169. doi:10.1186/1471-2148-L8-169.
5. Stanyon R., Rocchi M., Capozzi O., Roberto R., Misceo D., Ventura M., Cardone M.F., Bigoni F., Archidiacono N. Primate chromosome evolution: ancestral karyotypes, marker order and neocentromeres. Chromosome Res. 2008, 16:17-39.
6. Nagle C, Paul N., Mazzoni I., Quiroga S., Torres M., Mendizabal A.F., Farinati Z. Interovarian relationship in the secretion of progesterone during the lutean phase of the capuchin monkey (Cebus apella). J. Reprod. Fertil. 1989, 85:389-396.
7. Khosla P., Hajri T., Pronczuk A., Hayes K.C. Replacing dietary palmitic acid with elaidic acid (t-C18:1Δ9) depresses HDL and increases CETP activity in Cebus monkeys. J. Nutr. 1997, 127:531S-536S.
8. Peacock L., Hansen L., Morkeberg F., Gerlach J. Chronic dopamine D1, dopamine D2 and combined dopamine D1 and D2 antagonist treatement in Cebus apella monkeys: antiamphetamine effects and extrapyramidal side effects. Neuropsychopharmacology 1999, 20:35-43.
9. Colombo J, Napp M., Yañez A., Reisin H. Tissue printing of astroglial interlaminar processes for human and non-human primates cerebral cortex. Brain Res. Bull. 2001, 55:561-565.
10. Ando K. Test methods for predicting tardive toxicity of therapeutic drugs using laboratory animals. J. Toxicol. Sci. 1996, 21:105-107.
11. A. Borrell, Els efectes de las rediaciones ionitzans en el cromosomes de C. apella (Paltyrrhini), E. patas i M. fascicularis (Catarrhini), Tesis Doctoral Universidad Autónoma de Barcelona, España, 1995, 181pp.
12. Gold L.S., Manley N.B., Slone T.H., Rohrbach L. Supplement to the carcinogenic potency database (CPDB): results of animal bioassays published in the general literature in 1993-1994 and by the National Toxicology Program in 1995-1996. Environ. Health Perspect. 1999, 107:3-123.
13. Dobias L. Human blood mutagenicity for Salmonella typhimurium tester strains after oral application of entizol. Mutat. Res. 1980, 77:357-360.
14. Roe F.J. Toxicologic evaluation of metronidazole with particular reference to its carcinogenic mutagenic and teratogenic potential. Surgery 1983, 93:158-164.
15. Matula T. Validity of in vitro testing. Drug Metab. Rev. 1990, 22:777-787.
16. Mudry M.D., Carballo M.A., Labal de Vinuesa M., González Cid M., Larripa I. Mutagenic bioassay of certain pharmacological drugs. III. Metronidazole (MTZ). Mutat. Res. 1994, 305:127-132.
17. Mudry M.D., Martinez-Flores I., Palermo A.M., Carballo M.A., Egòzcue J., García-Caldés M. Embryolethality induced by metronidazole (MTZ) in Rattus norvegicus. Teratogen. Carcinog. Mutag. 2001, 21:197-205.
18. Mattila J., Männistö P., Mäntylä R., Nykänen S., Lamminsivu U. Comparative pharmacokineticsof metronidazole and tinidazole as influenced by the administration route. Antimicrob. Agents Chemother. 1983, 23:721-725.
19. K. Soares de Poça, Avaliação do efeito genotóxico do megazol, Fundação Oswaldo Cruz, Tesis de maestria, 2005.
20. López Nigro M.M., Mudry M.D., Carballo M.A. Metronidazole: Short term tests and cell death induced under aerobic condition. Lat. Am. J. Pharm. 2010, 29:1319-1327.
21. López Nigro M., Palermo A.M., Mudry M.D., Carballo M. Cytogenetic evaluation of two nitroimidazole derivatives. Toxicol. In Vitro 2003, 17:35-40.
22. Çelik A., Ateş N.A. The frequency of sister chromatid exchanges in cultured human peripheral blood lymphocyte treated with metronidazole in vitro. Drug Chem. Toxicol. 2006, 29:85-94.
23. Mudry M.D., Palermo A.M., Merani S.M., Carballo M.A. Metronidazole induced alterations in murine spermatozoa morphology. Reprod. Toxicol. 2007, 23:246-252.
24. López Nigro M.M., Carballo M.A. Genotoxicity and cell death induced by tinidazole (TNZ). Tox. Lett. 2008, 180:46-52.
25. Castelli M., Malagonli M., Ipazzio R., Baggio A., Castolari C., Vermelli C., Bossa M., Rossi T., Paolucci F., Rofia S. In vitro studies of two 5-nitroimidazole derivatives. J. Antimicrob. Chemother. 1997, 40:19-25.
26. Cosar C., Ganter P., Julou L. Etude experimentale du metronidazole 8223RP: activite trochomonicide et amoebicide. Toxicité et proprieté pharmacologique générales, Presse Medicale 1969, 69:1969-1972.
27. Teicher B., Herman T.S., Shulman G., Bubley C., Coleman N., Fre E. Combination of etanidazole with cyclophosphamide and platinum complexes. Cancer Chemother. Pharmacol. 1991, 28:153-158.
28. Robinson D., Abdel-Rachman S., Nahaya M. Guidelines for the treatment of Helycobacter pylori in the pediatric population. Ann. Pharmacother. 1997, 10:1247-1249.
29. Palermo A.M., Reynoso J., López Nigro M.M., Carballo M.A., Mudry M.D. Teratogenic evaluation of metronidazole and ornidazole using Drosphila melanogaster as an experimental model. Birth Defects Res. (Part A) 2004, 70:157-162.
30. Carballo M.A., Martinez R.A., Mudry M.D. Nitroimidazole derivatives: non-randomness sister chromatid exchanges in human peripheral blood lymphocytes. J. Appl. Toxicol. 2008, 29:248-254.
31. García F., Nogués C., Ponsà M., Ruiz-Herrera A., Egòzcue J., García Caldés M. Chromosomal homologies between humans and Cebus apella (Primates) revealed by ZOO-FISH. Mammal Genome 2000, 11:399-401.
32. W. Martindale, Plasmatic concentration of antiparasitic drugs in man, in: J. Reynolds (Ed.), Extra Pharmacopeia, The Pharmaceutical Press, London, UK, 1993, pp. 516-523.
33. Mudry M.D. Cytogenetic variability within and across populations of Cebus apella in Argentina. Folia Primatol. 1990, 54:206-216.
34. Perry P., Wolf S. New Giemsa method for differential staining of sister chromatids. Nature 1974, 261:156-158.
35. Miller B.M., Adler I.D. Suspect spindle poisons: analysis of c-mitotic effects in mouse bone marrow cells. Mutagenesis 1989, 4:208-215.
36. Carballo M.A., Palermo A.M., Mudry M.D. Toxicogenetic evaluation of metronidazole treatment in Trichomona vaginalis infected women. Ann. Trop. Med. Parasitol. 2004, 98:139-147.
37. Statsoft Inc., STATIS/TICA for Windows, Computer Program Manual, Tulsa, OK, USA, 1996, http://www.statsoftinc.com/.
38. Mudry M.D., Labal de Vinuesa M.L., Brieux de Salum S. Étude cytogénétique du Cai D'Argentine (Cebus apella). Ann. Génét. 1984, 27:102-105.
39. Molinari G., Soloneski S., Reigosa M.A., Larramendy M.L. In vitro genotoxic and cytotoxic effects of ivermectin and its formulation ivomec® on Chinese hamster ovary (CHOK1) cells. J. Haz. Mat. 2009, 165:1074-1082.
40. Borrell A., Ponsá M., Egòzcue J., Rubio A., García Caldés M. Chromosome abnormalities in peripheral blood lymphocytes from Cebus apella (Cebidae, Platyrrhini) alter X-ray irradiation. Mutat. Res. 1998, 401:65-76.
41. Mudry M.D., Fundia A., Hick A., Gorostiaga M. Labilidad cromosómica: una posible explicación en el origen de los reordenamientos cromosómicos en Cébidos. Bol. Primatol. Lat. 1995, 5:7-15.
42. Sutherlands G.R., Richards R.I. Fragile sites-cytogenetic similarity with molecular diversity. Am. J. Hum. Genet. 1999, 64:354-359.
43. Carlá Campá M., Stanyon R. Sequence of late DNA replication in Cebus capucinus: chromosomes and a standardized G banded karyotype. Am. J. Primatol. 1999, 29:205-212.
44. Schweizer D. Vergleichende Untersuchungen zur Längsdifferenzierung der chromosomen von Vicia faba L. Verhoeven Naturforsch. Ges. 1974, 83:1-75.
45. Natarajan A., Klasterna I. Heterochromatin and sister chromatid exchanges in the chromosomes of Microtus agrestis. Hereditas 1975, 79:150-154.
46. Thelma B., Rao S. In vivo SCE in the euchromatin and heterochromatin of the Indian mole rat, Nesokia indica. Cytogenet. Cell Genet. 1982, 33:319-326.
47. Carrano A., Wolf S. Distribution of SCE in the euchromatin and heterochromatin of the Indian Muntjac. Chromosoma 1975, 53:361-369.
48. Bostock J.C., Christie S. Analysis of the frequency of sister chromatid exchange in the kangaroo rat. Chromosoma 1976, 56:275-277.
49. Hsu T.C., Pathak S. Silver-stained structures in mammalian meiotic prophase. Chromosoma 1976, 70:195-203.
50. Fundia A., Gorostiaga M.A., Hick A., Mudry M.D. Expression of common fragile sites (FS) in two Ceboidea species: Saimiri boliviensis and Alouatta caraya (Primates, Platyrrhini). Genet. Sel. Evol. 2000, 32:87-97.